Telemonitoring for IBD Goodness Examination in Russia

Launched by RESEARCH AND PRACTICAL CLINICAL CENTER FOR DIAGNOSTICS AND TELEMEDICINE TECHNOLOGIES OF THE MOSCOW HEALTH CARE DEPARTMENT · Aug 8, 2023

Keywords

ClinConnect Summary

Number of volunteers: 64 patients with IBD Study duration: 18 months (12 months - patient enrollment, 6 months - telemonitoring).

Inclusion criteria:

* Age ≥18 years old.
* Signed informed consent.
* Diagnosis: Crohn disease (ICD-10 codes K50.0, K50.1, K50.8, K50.9) and Ulcerative colitis (K51.0, K51.2, 51.3, K51.5, K51.8);
* Treatment in the Gastroenterology Department in Sechenov University Hospital at the moment of trial start.

Exclusion criteria:

* Severe cognitive dysfunction;
* Acute mental illness;
* Lack of technical ability to take part in telemedical intervention (does not hav...

Gender

ALL

Eligibility criteria

• IInclusion criteria:
• • Age ≥18 years old.
• • Signed informed consent.
• • Diagnosis: Crohn disease (ICD-10 codes K50.0, K50.1, K50.8, K50.9) and Ulcerative colitis (K51.0, K51.2, 51.3, K51.5, K51.8);
• • Treatment in the Gastroenterology Department in Sechenov University Hospital at the moment of trial start.
• Exclusion criteria:
• • Severe cognitive dysfunction;
• • Acute mental illness;
• • Lack of technical ability to take part in telemedical intervention (does not have the skills to work with a smartphone, computer, tablet, there is no appropriate technical means);
• • Participation in other clinical studies.
• • Oncological diseases requiring active treatment.
• • Patients who denied signing informed consent.
• • Severe decompensation of cogent comorbid ailment;
• • Inability to understand written Russian;
• • Pregnant individuals.